ArticleFrontiers in immunology2025

Peripheral blood inflammatory score using a cytokine multiplex assay predicts clinical outcomes in patients treated with atezolizumab-bevacizumab for unresectable HCC.

Hee Sun Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.